Daewon Pharmaceutical Co., Ltd. (KRX:003220)
12,540
+40 (0.32%)
At close: Dec 5, 2025
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 268.78 billion as of December 5, 2025. Its market cap has decreased by -12.73% in one year.
Market Cap
268.78B
Enterprise Value
421.66B
Revenue
590.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,540.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 268.78B, an increase of 1,388.24%. That is a compound annual growth rate of 11.51%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.11T |
| ALTEOGEN | 27.92T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,906.05B |
| Peptron | 6,668.76B |